UK school leavers and new students to be offered meningitis B vaccine

The UK government is launching a one-off vaccination program to offer meningitis B protection to around one million young people. This initiative comes in response to an unprecedented outbreak of the disease in Kent earlier this year, as well as clusters in Dorset and Berkshire, which tragically led to the deaths of three young individuals. Although the cases involved different strains of meningitis B, the vaccine, known as Bexsero, is expected to cover most of them. The vaccination requires two doses, administered at least 28 days apart, and is believed to offer protection for at least six years. The program targets teenagers in their final school year and young people under 25 starting university or moving into similar residential further education settings for the first time this autumn, including international students. Health Secretary James Murray stated that the Kent outbreak and recent clusters suggest a potential shift in how meningitis B affects people. Acting now, he explained, aims to protect those at the highest immediate risk as they enter university and residential colleges. Offering two doses before the academic year begins is intended to reduce the risk of serious illness and larger outbreaks. The UK Health Security Agency noted that invasive meningococcal disease cases typically peak in October and November. Eligible students are urged to receive their doses in July and August for peace of mind as they begin their studies. Caroline Temmink, director of vaccination at NHS England, confirmed that eligible individuals will be contacted directly via the NHS app, text, and email, with those starting university able to book appointments at available pharmacies.

“

The Kent outbreak and recent clusters indicate a possible change to the way MenB affects people. While we assess the latest evidence, we are acting now to help protect young people at highest immediate risk as they enter university and residential colleges this autumn.